Table 4.

The relative expression of the target proteins in the control, cisplatin, and 0.64 mg/mL SPS groups

Groups	Bcl-2	COX-2	Bax	Cleaved caspase-3
Control (24 h)	0.723 ± 0.121	0.918 ± 0.095	0.282 ± 0.164	0.464 ± 0.091
Control (48 h)	0.719 ± 0.196	0.922 ± 0.132	0.283 ± 0.053	0.460 ± 0.021
Control (72 h)	0.733 ± 0.198	0.899 ± 0.210	0.290 ± 0.026	0.465 ± 0.018
Cisplatin (24 h)	0.442 ± 0.113*	0.661 ± 0.066*	0676 ± 0.103*	0.679 ± 0.093*
Cisplatin (48 h)	0.393 ± 0.045*	0.458 ± 0.072*	0.867 ± 0.064*	0.863 ± 0.123*
Cisplatin (72 h)	0.107 ± 0.062	0.237 ± 0.069	0.916 ± 0.093*	0.991 ± 0.133*
SPS (24 h)	0.513 ± 0.101*	0.795 ± 0.135*	0.740 ± 0.0858	0.602 ± 0.076*
SPS (48 h)	0.392 ± 0.083*	0.590 ± 0.099*	0.920 ± 0.083*	0.764 ± 0.063*
SPS (72 h)	0.206 ± 0.106*	0.435 ± 0.021*	1.832 ± 0.925*	0.948 ± 0.089*

SPS safflower polysaccharide. *P < 0.05 compared with the control group